Author: AQUAPASS

HCM & HRIS

AQUAPASS Completes Enrollment in REFORM-HF Pivotal Trial, Results to Be Presented at Major Heart Failure Conference This Fall

August 11, 2026
AQUAPASS
No Comments

, /PRNewswire/ — AQUAPASS, developer of a noninvasive, kidney-independent therapy for fluid overload management in patients…